The role of MT1-MMP in the progression and metastasis of osteosarcoma
作者机构:Institute of Cancer TherapeuticsFaculty of Life SciencesUniversity of BradfordBradford BD71DPUK
出 版 物:《Journal of Cancer Metastasis and Treatment》 (癌症转移与治疗(英文版))
年 卷 期:2022年第8卷第1期
页 面:564-578页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
基 金:This work was supported by the Bone Cancer Research Trust (No. BCRT 6218).
主 题:Matrix metalloproteinase membrane-type osteosarcoma MT1-MMP
摘 要:The dysregulation of Membrane-type 1 matrix metalloproteinase(MT1-MMP)has been extensively studied in numerous cancer types,and plays key roles in angiogenesis,cancer progression,and metastasis.MT1-MMP is a predictor of poor prognosis in osteosarcoma(OS),yet the molecular mechanisms of disease progression are unclear.This review provides a summary of the literature relating to the gene and protein expression of MT1-MMP(MMP-14)in OS clinical samples,evaluates the expression in cell lines and experimental models,and analyses its potential role in the progression and metastasis of OS.In addition,the therapeutic potential of MT1-MMP as a drug target has been assessed.Due to the biological complexity of MMPs,inhibition has proven to be challenging.However,exploiting the expression and proteolytic capacity of MT1-MMP could open new avenues in the search for novel,safer and selective drugs for use in OS.